This article is translated by AI company Flitto and Alhpa Biz neural machine translation technology
 |
| 삼성바이오로직스 인천 송도 공장 (사진=삼성바이오로직스) |
[Alpha Biz=(Chicago) Reporter Paul Lee] Samsung BioLogics announced on the 17th that it has decided to invest in new facilities worth 1.98 trillion won.
This is equivalent to 22.01% of equity capital, and the investment period is until September 30, 2025. It is planning to build 5 factories in Songdo 2nd Bio Campus.
Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)
